Forbion Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 25
Professionals
  • Investments
  • 143
  • Portfolio
  • 22
  • Exits
  • 70
Exits

Forbion General Information

Description

Founded in 2006, Forbion is a venture capital firm based in Naarden, Netherlands. The firm works closely with entrepreneurs to build life sciences companies with technologies and products designed to transform people's lives. The firm is a signatory to the United Nations Principles for Responsible Investment. Besides financial objectives, the firm selects investments that will positively affect the health and well-being of patients. The firm also operates a joint venture with BioGeneration Ventures, which manages three separate seed and early-stage funds focused on Benelux and Germany

Contact Information

Website
Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Impact Investing
Primary Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands
+31 035 000 0000

Forbion Investments (143)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
NewAmsterdam Pharma 14-Jan-2021 Early Stage VC 00000 Drug Discovery Clinical Trials - General 00000000 00000
00000000 000000000 19-Nov-2020 00000 00000 0000 Drug Discovery Clinical Trials - General 000000 0000000000 00.0
00000 000000000000 11-Nov-2020 00000 00000 000.00 Drug Discovery Clinical Trials - General 0000 0000000
0000000 10-Nov-2020 00000 00000 000.00 Drug Discovery Generating Revenue 000000 0000000000 00.0
000000000 08-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - General 00000 0000000 00
000000000000 00000 25-Aug-2020 0000 00000 000.00 Drug Discovery Clinical Trials - General 000000 00000000
0000 000000000000 10-Aug-2020 00000 00000 00000 Drug Discovery Pre-Clinical Trials 0000 0000000
00000000 03-Jun-2020 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 3 00000-000 000000 00
AM-Pharma 31-Mar-2020 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 3 00000-000 000000 00
Azafaros 06-Feb-2020 Early Stage VC 000.00 Drug Discovery Generating Revenue 000000 00000000
You’re viewing 10 of 143 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Forbion Exits (70)

Company Name Exit Date Exit Type Exit Size
Inflazome 21-Sep-2020 Merger/Acquisition 00000
0000 000000000000 17-Sep-2020 000 00000
00000 000000000000 09-Sep-2020 000000000000000000
000000000 13-Feb-2020 000000000000000000 00.000
0000 000000 01-Oct-2019 000 00 00000000
000000000 00000000 01-Sep-2019 000000000000000000
000000000 00000000 13-May-2019 000 000.00
0000000 000000 18-Apr-2019 000 0000
Mitralign 12-Mar-2019 Merger/Acquisition
Staten Biotechnology 17-Dec-2018 Merger/Acquisition 00000
You’re viewing 10 of 70 exits. Get the full list »

Forbion Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Forbion‘s full profile, request access.

Request a free trial

Forbion Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Forbion Team (33)

Name Title Deals Funds Boards Office
Vincent van Houten Chief Financial Officer & General Partner 0 0 Naarden, Netherlands
Martien van Osch Co-Founding Partner & Managing Partner 00 0 0 Naarden, Netherlands
Geert-Jan Mulder MD Managing Partner and Co-Founding Partner 00 0 0 Naarden, Netherlands
Sander Slootweg Co-Founder & Managing Partner 0 0 0 Naarden, Netherlands
Holger Reithinger Ph.D General Partner 00 0 0 Munich, Germany
You’re viewing 5 of 33 team members. Get the full list »

Forbion Co-Investors (107)

Name With Exits Lead Partner Series Industry
BioGeneration Ventures 4 0 Series chart Industry bar
Fountain Healthcare Partners 0 0 0 Series chart Industry bar
Novartis Venture Fund 0 0 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
You’re viewing 5 of 107 co-investors. Get the full list »